Padmanabha shenoy retweeted
🔥 Fiery Debate at #VasculitisConclave Jaipur!
Student vs. Teacher clash 👇
🧑🎓 @drdpshenoy (AGAINST)
🧑🏫 Dr. Vikas Agarwal (FOR)
Topic: Role of antifibrotics in ANCA vasculitis 🫁💥
A battle of data, perspectives & passion—science at its best!
Padmanabha shenoy retweeted
#OARC update: Takeaways from SSc ILD from @drdpshenoy. 1.SSc ILD- Highest SMR among CTD ILD. 2. Max. Lung volume loss seen in first few yrs 3. Scl70 ⬆️ & centromere⬇️ risk of ILD 4.Get HRCT at baseline in Scl 70+,early disease 5. FVC < 80% predicts poor survival 5.🎯FVC⚖️
Padmanabha shenoy retweeted
Replying to @drdpshenoy
@drdpshenoy sheds light on PRP Therapy in OA - most exciting current practice !
1. evidence is inconsistent across studies
2. Standard PRP preparation ( platelet rich and leucocyte depleted) is the key for better outcomes
3. Better longer Efficacy compared to steroids
Indigo service off late has deteriorated Faced similiar things in last 6 mths. If indigo which has 2/3 market share performs badly it will pull down Indian aviation. Sharing the experience of India's one of the most respected rheumatologis. @Officejmscindia @IndiGo6E @PMOIndia
Spoke on will human edit their genes ? At #klf2024. My answer was yes. Only question is when? We discussed on ethical aspects of gene editing and need for regulations etc. Very glad to see full house for this science session. Thanks DC books for facilitating the event.
22
631
Padmanabha shenoy retweeted
Takeaways from #ACR23 #ReviewCourse session on Thrombotic Microangiopathy - Dr. Thomas Ortel
1. The primary thrombotic microangiopathies (TMAs) are TTP (thrombotic thrombocytopenic purpura) & CM-HUS (complement-mediated hemolytic uremic syndrome) and treatement needs to be directed at primary hematologic mechanism, regardless of whether there is an underlying conditon such as SLE or APS.
2. Treatment of TTP: Plasma exchange (improves survival from 10% to 80-90%), steroids, consider caplacizumab (binds vWF and inhibits adhesion of platelets). Monitor ADAMTS13 levels.
3. CM-HUS. Classically associated with shiga toxin, but most are considered "atypical"/noninfectious related and may have a +family history and complement mutations. Often have low C3/normal C4 but there is no diagnostic test. Treatment targets C5 blockade with eculizumab or revalizumab (only small studies). Plasma exchange can be stopped if ADAMTS13 activity >10%.
Padmanabha shenoy retweeted
Takeaways from #ACR23 #ReviewCourse session on Update on Relapsing Polychondritis - Dr. Marcela Ferrada
1. Be aware of common/uncommon manifestations (see slide). Affects more than just the ear!!!
2. Collagen II antibodies: not really sensitive or specific for diagnosis. Biopsy helpful but limited usefulness.
3. RP is a very heterogenous disease, likely multiple diseases.
- Type 1 (typical): ear/nose/tracheal/joint inflammation with significant inflammation and damage.
- Type 2: upper/lower airway involvement - workup includes: ENT eval w/ laryngoscopy, PFTs, dynamic CT Scan, pulm consult/bronchoscopy. Often diagnosed as "adult onset asthma" but actually have brochomalacia.
- Type 3 (most common): arthalgias/myalgias, Raynaud's, sicca symptoms, opthalmloplegia. Think of MAGIC and VEXAS. Ask about genital ulcers = MAGIC syndrome).
4. VEXAS syndrome. 60% of VEXAS patients have RP. Summary of VEXAS from ChatGTP4: "This syndrome is characterized by the development of vacuoles in myeloid and erythroid precursors, is associated with mutations in the UBA1 gene (which encodes for a ubiquitin-activating enzyme E1), is inherited in an X-linked manner, leads to autoinflammatory manifestations, and is caused by somatic mutations."
4. No specific treatments for RP: MTX, LEF, steroids, TNFi, IL-6 commonly used.
Very important practise tip Combining mmf with PPI or H2 blockers reduces drug levels close to 50 % and may result in lack of therapeutic response. If patient has gerd use enteric coated sodium salt. Our recent paper in seminars in arthritis and rheumatism.
Sad to see. He speaks science. 😞
engaluru Civil Court passes ex-parte injunction order to X to suspend the account of Dr Cyriac Abby Philips (@theliverdoc).
The order was passed in a suit filed by Himalaya Wellness Corporation which alleged that @theliverdoc made defamatory allegations against the company.
Padmanabha shenoy retweeted
Replying to @drdpshenoy
200 Biologic naive #RA pts in remission under csDMARD tapering and withdrawal while given either placebo or oral curcumin (1 g bid). Flare-free survival at 52 wks was similar between groups (60% vs 64%; p = 0.76). Time to flare was similar (219d vs 214d) bit.ly/45RBHto
Padmanabha shenoy retweeted
Ok listen to this.
It's about a new study on curcumin.
This is the largest clinical study that looked at benefits of curcumin (bioactive compound in turmeric) for persons with rheumatoid arthritis.
This was not a run-of-the-mill study. This was well-designed, beautifully executed, double blinded, randomized-controlled trial with 200 patients, followed up for a whole year.
Curcumin, considered the main anti-inflammatory & anti-oxidant component of turmeric, and turmeric are considered hot favorites for fighting diseases like cancer, infections, systemic inflammatory diseases like inflammatory bowel disease and many rheumatic diseases - based on cellular, tissue and small animal and small, poor quality human trials.
But this paper, a well performed, painstakingly designed and meticulously folllwed up study is superior to every other study done on curcumin.
And what the authors found was insane, but not surprising.
Curcumin treatment for maintaining remission of rheumatoid arthritis was as good as no treatment. In simple terms, it was absolutely useless.
It's time the scientific community stop clinical studies featuring curcumin/turmeric. It's a waste of funds, complete waste of human resources and a delay for the need to study better molecules/compounds.
The same goes for application of turmeric over wounds and use of turmeric milk to fight infections, reduce sore throat, and build immunity. It's all grand imagination from great grand parents, handed down generations who have lost the ability for critical thinking. The best that turmeric in milk can do, is color whole milk yellow, and worst, it can give you Lead poisoning.
Even worse, high absorption formulations can give you a new liver because turmeric is liver toxic.
In strict medical sense, turmeric is a waste of your time. But it's a kickass spice in the great Indian kitchen. So enjoy it in your curries, not capsules.
Great work from @drdpshenoy and team on this paper from the Centre for Arthritis and Rheumatism Excellence (CARE), Kochi, Kerala, link.springer.com/article/10…
Thanks for the kind words
Replying to @drdpshenoy
Congratulations to all of you! This is by far the best drug withdrawal study in #Rheumatoidarthritis.
7
1,043
Padmanabha shenoy retweeted
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
In Arthritis & Rheumatology
loom.ly/3GI96GQ
jointly supported by @acr_rheum and @eular_org
Our one year rct of 200 rheumaoid arthritis patients in Remission. During DMARD withdrawal Curcumin was as good as placebo. Published today. Frankly speaking we did the study hoping it will work. But science triumphs.
Thanks to @sakir_rheum @PanktiMehta24 for the support
Link to study
link.springer.com/article/10…
Thanks all the faculty and participants. This is just a beginning. 👍🙏
A wonderful beginning...
Thanks to @drdpshenoy @chengappa_kg And the wonderful faculty @PanktiMehta24 @reallyrudi91 @Sanket_Rheumat @jainavinash
12
871
Padmanabha shenoy retweeted
Amazing and fun way to learn Immunology!
From Basics to Tanslation; B2T
Thanks to Shenoy sir and amazing seniors for making it possible!
@drdpshenoy @PanktiMehta24 @jainavinash @sakir_rheum @Sanket_Rheumat @SandhyaRheumat
Our latest publication showing how hybrid immunity protects against omicron
Our latest paper on breakthrough #omicron infections in vaccinated patients with rheumatic diseases
👉Infection rate- 17.4%
👉Risk is significantly ⏫ in vaccine only vs hybrid (vaccine+ past #COVID19 infection) group
link.springer.com/article/10…
#rheumtwitter




































